Page last updated: 2024-10-24

chlordiazepoxide and Prader-Willi Syndrome

chlordiazepoxide has been researched along with Prader-Willi Syndrome in 1 studies

Chlordiazepoxide: An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
chlordiazepoxide : A benzodiazepine that is 3H-1,4-benzodiazepine 4-oxide substituted by a chloro group at position 7, a phenyl group at position 5 and a methylamino group at position 2.

Prader-Willi Syndrome: An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fieldstone, A1
Zipf, WB1
Sarter, MF1
Berntson, GG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome[NCT05541003]Phase 212 participants (Actual)Interventional2023-01-06Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for chlordiazepoxide and Prader-Willi Syndrome

ArticleYear
Food intake in Prader-Willi syndrome and controls with obesity after administration of a benzodiazepine receptor agonist.
    Obesity research, 1998, Volume: 6, Issue:1

    Topics: Adolescent; Adult; Child; Chlordiazepoxide; Eating; Female; GABA-A Receptor Agonists; Humans; Male;

1998